CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee
Clin Exp Pediatr. 2014;57(2):55-66.   Published online February 24, 2014
DOI: https://doi.org/10.3345/kjp.2014.57.2.55

Excel Download

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee
Korean Journal of Pediatrics. 2014;57(2):55   Crossref logo
Link1
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
Patricia Izurieta, Michael Scherbakov, Javier Nieto Guevara, Volker Vetter, Lamine Soumahoro
Human Vaccines & Immunotherapeutics. 2022;18(1):   Crossref logo
Link1
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006)
Froukje Oosterhuis-Kafeja, Philippe Beutels, Pierre Van Damme
Vaccine. 2007;25(12):2194-2212   Crossref logo
Link1 Link2
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development
Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Mary Slack
Vaccine. 2020;38(51):8068-8070   Crossref logo
Link1 Link2
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
Bruce A. Mungall, Bernard Hoet, Javier Nieto Guevara, Lamine Soumahoro
Expert Review of Vaccines. 2022;21(2):201-214   Crossref logo
Link1
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines – Authors' reply
David Goldblatt, Shabir A Madhi
The Lancet Infectious Diseases. 2019;19(7):693-694   Crossref logo
Link1 Link2
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines
Bradford D Gessner, Heather L Sings, Luis Jodar
The Lancet Infectious Diseases. 2019;19(7):692-693   Crossref logo
Link1 Link2
Effectiveness of three pneumococcal conjugate vaccines (PCV) to prevent invasive pneumococcal disease in Quebec, Canada
Alejandro Cané, Bettina Hamelin, Raul Isturiz
Vaccine. 2016;34(18):2051-2052   Crossref logo
Link1 Link2
Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
Steven Black, Juhani Eskola, Cynthia Whitney, Henry Shinefield
Vaccines. 2008;531-567   Crossref logo
Link1 Link2
Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors
Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman
American Journal of Preventive Medicine. 2021;61(1):28-36   Crossref logo
Link1 Link2